CACNA1D-PRKCD Fusion FISH Probe
The CACNA1D-PRKCD Fusion FISH Probe is used to confirm a fusion of the CACNA1D and PRKCD genes. The fusion of the CACNA1D and PRKCD genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CACNA1D-PRKCD-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CACNA1D-PRKCD-20-AQAQ | 20 (40 μL) | 200 μL |
|
CACNA1D Gene Summary
Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Gene Name: Calcium Voltage-gated Channel Subunit Alpha1 D
Chromosome: CHR3: 53529030 -53846492
Locus: 3p21.1
PRKCD Gene Summary
The protein encoded by this gene is a member of the protein kinase C family of serine- and threonine-specific protein kinases. The encoded protein is activated by diacylglycerol and is both a tumor suppressor and a positive regulator of cell cycle progression. Also, this protein can positively or negatively regulate apoptosis. Defects in this gene are a cause of autoimmune lymphoproliferative syndrome. [provided by RefSeq, Aug 2017]
Gene Name: Protein Kinase C Delta
Chromosome: CHR3: 53195222 -53226733
Locus: 3p21.1
Gene Diseases
The CACNA1D PRKCD Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|